abstract |
The present invention relates to a method of treating and / or preventing a degenerative inflammatory process in a tissue of a subject, the method comprising increasing the activity of Toll-like receptor 3 (TLR3) in cells of the tissue. In a preferred embodiment, the TLR3 agonist is stathmin or a stathmin-like protein such as SCG10, SCLIP or RB3. [Selection figure] None |